Avasa
Auckland, New Zealand· Est.
Avasa builds an automated microvascular connector to replace hand‑sewing, speeding microsurgery and improving outcomes.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Avasa builds an automated microvascular connector to replace hand‑sewing, speeding microsurgery and improving outcomes.
Microvascular surgeryTransplant surgeryReconstructive surgery
Technology Platform
A robotic micro‑actuation system combined with OCT guidance and a photo‑curable bio‑adhesive to create rapid, suture‑free vascular anastomoses.
Opportunities
First‑in‑human trials could unlock adoption in high‑volume vascular and transplant centers, creating a new standard for microsurgical anastomosis.
Risk Factors
Regulatory clearance timelines, surgeon adoption barriers, and technical validation of the adhesive’s long‑term biocompatibility.
Competitive Landscape
Competes with traditional suturing and existing coupler devices; differentiation lies in universal vessel size applicability and fully automated, suture‑free connection.